1. Earlier use of androgen receptor‐axis‐targeted drugs may improve overall survival in patients with non‐metastatic castration‐resistant prostate cancer. Issue 10 (10th April 2018) Authors: Mori, Keiichiro; Kimura, Takahiro; Ito, Kagenori; Onuma, Hajime; Tanaka, Masatoshi; Matsuura, Taishi; Kurokawa, Gaku; Iwatani, Kosuke; Inaba, Yuzo; Sakanaka, Keigo; Sasaki, Hiroshi; Miki, Jun; Shimomura, Tatsuya; Miki, Kenta; Egawa, Shin Journal: Prostate Issue: Volume 78:Issue 10(2018) Page Start: 766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗